|
|
|
| Clinical Value of Cervista HR-HPV DNA Combined with TCT in Cervical Cancer Screening |
| YU Le, et al |
| Chengde Maternal and Child Health Hospital, Hebei Chengde 067000, China |
|
|
|
|
Abstract Objective: To study the clinical value of cervista HR-HPV DNA combined with TCT in cervical cancer screening, 500 suspected cervical cancer patients were selected and tested with single cervista HR-HPV DNA, single TCT and cervista HR-HPV DNA combined with TCT. Methods: A total of 500 patients with suspected cervical cancer were selected. Time selection: February 2016 to February 2018, respectively, single cervista HR-HPV DNA test, single TCT test, cervista HR-HPV DNA combined with TCT test, pathological results as a diagnostic gold standards were used to analyze the data of diagnostic specificity, sensitivity, and accuracy of single cervista HR-HPV DNA assay, single TCT assay, and cervista HR-HPV DNA combined with TCT assay. Results: Compared with the single cervista HR-HPV DNA test and single TCT test data, the data of the cervista HR-HPVDNA parallel TCT test was higher than that of the single cervista HR-HPV DNA test. The data difference was significant, P<0.05. However, the cervista HR-HPV DNA was connected in parallel. The diagnostic specificity of TCT was lower than that of single cervista HR-HPV DNA and single TCT. The data was significantly different (P<0.05). The diagnostic specificity, sensitivity and accuracy of single cervista HR-HPV DNA were higher than single TCT. Data were detected and the data were significantly different, P<0.05. Conclusion: The clinical value of cervista HR-HPVDNA combined with TCT in cervical cancer screening is significant, which can improve the diagnostic value of patients and obtain higher diagnostic specificity, sensitivity and accuracy.
|
|
|
|
|
|
[1] Stephanie S. Liu,Karen K. L. Chan,Daniel K. H. Chu, et al.Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer[J].Molecular Oncology,2018,12(12):2009~2022.
[2] UlainQurat,HanLu,WuQian, et al.Indocyanine green can stand alone in detecting sentinel lymph nodes in cervical cancer[J].Journal of International Medical Research,2018,46(12):4885~4897.
[3] Yingji Jin,Jae Woong Choi,Hyoung Jin Kim, et al.Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer[J].Cancer Medicine,2018,7(11):5655~5664.
[4] T. Kurokawa,T. Onuma,A. Shinagawa, et al.The ideal strategy for cervical cancer screening in Japan: result from the fukui cervical cancer screening study[J].Cytopathology,2018,29(4):361~367.
[5] Lisa A. Rubinsak,Le Kang,Emma C. Fields, et al.Treatment-related radiation toxicity among cervical cancer patients[J].International Journal of Gynecological Cancer,2018,28(7):1387~1393.
[6] 李娟,刘月红,顾萍,等.631例宫颈癌筛查结果分析[J].中国当代医药,2018,25(26):79~81.
[7] 郑小平,叶秀丽,陈翌琴.洞头区宫颈癌筛查结果分析[J].预防医学,2018,30(7):743~745.
[8] 陆春雪.宫颈癌筛查中阴道镜的应用[J].中国实用乡村医生杂志,2018,25(5):14~17. |
|
|
|
2019, Vol. 25 
